Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Habermann

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Trends in Pharmacological Sciences|June 1, 1994
Education in pharmacology. Comments from E. Habermann, University of Gieben, GermanyE Habermann
Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1970
[A new principle for the quantiative determination of high molecular weight antigens (junction test) and its application to tetanus toxin, serum albumin and ovalbumin]E Habermann
Medical Microbiology and Immunology|September 26, 1973
Discrimination between binding to CNS, toxicity and immunreactivity of derivatives of tetanus toxinE Habermann
Science (New York, N.Y.)|July 28, 1972
Bee and wasp venomsE Habermann
Pharmazie in Unserer Zeit|September 1, 1995
[Pharmacology and society]E Habermann
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1991
[Problems in long-term therapy from the viewpoint of the pharmacologist]E Habermann
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1971
Some general rules governing fate and action of polypeptide and protein drugs, as derived from investigations with staphylococcal alpha-toxin, tetanus toxin, and so-calledd crotoxinE Habermann
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 31, 1977
Transmembranal and intracellular transport of pharmacologically active proteins and polypeptidesE Habermann
Die Medizinische Welt|January 4, 1974
[Permeability and hemorrhage: mechanisms and possible mediators]E Habermann
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Mediators in shock processes: pathogenetic and therapeutic problems]E Habermann
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Trends in Pharmacological Sciences|June 1, 1994
Education in pharmacology. Comments from E. Habermann, University of Gieben, GermanyE Habermann
Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1970
[A new principle for the quantiative determination of high molecular weight antigens (junction test) and its application to tetanus toxin, serum albumin and ovalbumin]E Habermann
Medical Microbiology and Immunology|September 26, 1973
Discrimination between binding to CNS, toxicity and immunreactivity of derivatives of tetanus toxinE Habermann
Science (New York, N.Y.)|July 28, 1972
Bee and wasp venomsE Habermann
Pharmazie in Unserer Zeit|September 1, 1995
[Pharmacology and society]E Habermann
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1991
[Problems in long-term therapy from the viewpoint of the pharmacologist]E Habermann
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1971
Some general rules governing fate and action of polypeptide and protein drugs, as derived from investigations with staphylococcal alpha-toxin, tetanus toxin, and so-calledd crotoxinE Habermann
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 31, 1977
Transmembranal and intracellular transport of pharmacologically active proteins and polypeptidesE Habermann
Die Medizinische Welt|January 4, 1974
[Permeability and hemorrhage: mechanisms and possible mediators]E Habermann
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Mediators in shock processes: pathogenetic and therapeutic problems]E Habermann
Pageof 16